Everest Biolabs, Inc. · CIK 2116676
Everest Biolabs, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Mar 11, 2026
through Mar 11, 2026
through Mar 11, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $5,650,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $4,350,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Likely investment adviser (not guaranteed)
Best-effort name match against Form ADV. Click through for AUM, employees, and disciplinary disclosures.
-
EVEREST CAPITAL LLC
medium CRD 801-70964
Form D filings (1)
-
0002116676-26-000001D · Mar 11, 2026 · BiotechnologyOffering: $5,650,000Sold: $4,350,000